| Simagchem Corporation | China | Inquire | ||
|---|---|---|---|---|
![]() | www.simagchem.com | |||
![]() | +86 13806087780 | |||
![]() | +86 (592) 268-0237 | |||
![]() | sale@simagchem.com | |||
| Chemical manufacturer since 2002 | ||||
| chemBlink Standard supplier since 2008 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| AEchem Scientific Corporation | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.aechemsc.com | |||
![]() | +1 (630) 364-5106 | |||
![]() | +1 (630) 364-5107 | |||
![]() | info@aechemsc.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2012 | ||||
| Taizhou Tongxin Biopharmaceutical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.allyrise.com | |||
![]() | +86 18652728585 | |||
![]() | +86 (523) 8276-5215 | |||
![]() | sales@allyrise.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2013 | ||||
| chemBlink Standard supplier since 2013 | ||||
| Zhuhai Hairuide Bioscience and Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.zhhairuide.com | |||
![]() | +86 (756) 778-9199 +86 13326687259 +86 13326687289 +86 15913232160 | |||
![]() | +86 (756) 778-9099 | |||
![]() | sales@zhhairuide.com zhengyanhong@zhhairuide.com | |||
![]() | QQ Chat | |||
![]() | Skype Chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink Standard supplier since 2019 | ||||
| Classification | API >> Circulatory system medication >> Antihypertensive drug |
|---|---|
| Name | Fimasartan |
| Synonyms | 2-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one |
| Molecular Structure | ![]() |
| Molecular Formula | C27H31N7OS |
| Molecular Weight | 501.65 |
| CAS Registry Number | 247257-48-3 |
| Density | 1.25 |
|---|---|
| SDS | Available |
|---|---|
| Market Analysis Reports |
| List of Reports Available for Fimasartan |